Doctor profile · Federal record

Dr. Keith Lerro, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Wilson, NC

  • NPI 1730161092
  • Accepts Medicare
  • MIPS 88.4 / 100 · 2023
  • 29 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2624 Ortho Dr
Wilson, NC 278933484
(252) 991-5261
fax (252) 991-5262
Mailing address
2624 Ortho Dr W
Wilson, NC 278933484

Credentials & registration

NPPES · NUCC
NPI registered
November 2005 — 21 yrs on file
Profile last updated
September 14, 2012
Year of graduation
1997 — 29 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
North Carolina #200300489
Medicaid
NC #5920149

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1730161092. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
63,189
Distinct HCPCS
10
Medicare allowed
$1,230,819
HCPCS Description Services Patients Avg allowed
J3111 Injection, romosozumab-aqqg, 1 mg 19,740 16 $10
J0897 Injection, denosumab, 1 mg 17,588 121 $23
J1437 Injection, ferric derisomaltose, 10 mg 11,900 72 $21
J1100 Injection, dexamethasone sodium phosphate, 1 mg 2,290 40 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 2,199 522 $8
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 2,000 11 $8
36415 Insertion of needle into vein for collection of blood sample 1,048 448 $7
99214 Established patient office or other outpatient visit, 30-39 minutes 1,041 515 $123
96372 Injection of drug or substance under skin or into muscle 979 206 $14
J2469 Injection, palonosetron hcl, 25 mcg 610 15 $1

In context: peer comparison

Among 1 peers in Wilson Hematology & Oncology Physician, average services per provider: 1,620. This provider delivers 39× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$9,056
Transactions
114
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 13 $4,275.85
Janssen Biotech, INC. 7 $307.14
Dendreon Pharmaceuticals LLC 11 $269.51
Pfizer INC. 17 $250.63
Novartis Pharmaceuticals Corporation 13 $247.69
Merck Sharp & Dohme LLC 10 $238.46
Sobi, INC 4 $195.94
Eisai INC. 8 $164.89
Pharmacosmos Therapeutics INC. 6 $155.93
Incyte Corporation 4 $146.13
Daiichi Sankyo INC. 7 $144.15
BeiGene USA, INC. 4 $140.44
Spectrum Pharmaceuticals INC. 4 $134.36
Regeneron Healthcare Solutions, INC. 3 $119.07
Lilly USA, LLC 3 $118.05

By nature of payment

Food and Beverage
$4,866
Consulting Fee
$4,068
Education
$122

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,278
Patients
287
Total drug cost
$3,968,663
Drug Type Claims Patients Total cost
Anastrozole Generic 259 67 $6,222
Procrit (Epoetin Alfa) Brand 214 50 $514,453
Eliquis (Apixaban) Brand 112 25 $71,118
Xarelto (Rivaroxaban) Brand 93 17 $63,250
Lupron Depot (Leuprolide Acetate) Brand 71 16 $305,286
Revlimid (Lenalidomide) Brand 70 11 $1,851,980
Warfarin Sodium Generic 64 12 $1,028
Dexamethasone Generic 60 14 $1,007
Udenyca (Pegfilgrastim-Cbqv) Brand 58 11 $251,692
Oxycodone Hcl Generic 53 23 $1,762

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Keith Lerro's medical specialty?
Dr. Keith Lerro practices Hematology & Oncology Physician in Wilson, NC.
Where does Dr. Keith Lerro practice?
Dr. Keith Lerro practices at 2624 Ortho Dr, Wilson, NC 278933484. Office phone: 2529915261.
What is Dr. Keith Lerro's NPI?
Dr. Keith Lerro's National Provider Identifier (NPI) is 1730161092, issued by NPPES.
Does Dr. Keith Lerro accept Medicare assignment?
Yes. Dr. Keith Lerro accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Keith Lerro commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Injection, ferric derisomaltose, 10 mg (HCPCS J1437). Source: CMS Medicare Physician & Other Practitioners file.